Nuuvera, Inc (fka NUUVF)

[JohnCM]

About Nuuvera

Nuuvera is a global cannabis company founded on Canadian principles, and built with the whole world in
mind. Nuuvera is currently working with partners in Germany, Israel and Italy, and is exploring
opportunities in several other countries, to develop commercial production and global distribution of
medical grade cannabis in legalized markets. Through its subsidiaries, ARA – Avanti Rx Analytics Inc.
and Avalon Pharmaceutical Inc., Nuuvera holds a Dealer License (GMP) under the Narcotic Control
Regulations and Office of Controlled Substances. Nuuvera is currently in the final stages of the Health
Canada review process to become a Licensed Producer.

Nuuvera Germany breaks ground on facility for storage and packaging of medical cannabis

TORONTO, Jan. 9, 2018

Nuuvera Deutschland GmbH, a wholly-owned subsidiary of Nuuvera
Inc. ("Nuuvera") (TSXV: NUU), announced today that it has broken ground on the construction of a
storage and packaging facility for medical cannabis products.
Nuuvera recently purchased a 11,300 square-foot property in Bad Bramstedt, in northern Germany, to
build a premium vault storage system equipped with state-of-the-art security and related technology. The
facility is expected to meet the most stringent requirements for the storage of controlled substances in
Germany and the EU.
Lorne Abony, the CEO of Nuuvera, said that the new facility will ensure the company can continue to
develop into a major supplier of medical cannabis products to German consumers.
"This development is ground-breaking for Nuuvera," said Abony. "It is a critical element of our on-theground
operations in Germany and throughout Europe."
"With a market of 82-million people, Germany represents a key growth opportunity in this emerging and
rapidly growing global business", Abony continued.
Demand for medical cannabis products in Germany is expected to surge in the coming months and years.
Legislation passed in 2017 significantly eased consumer access to medical cannabis products. In the
German medical system, physicians and pharmacists work closely to ensure that patient needs are met
and that only the highest quality products are available.
The Nuuvera facility will be built in two phases. In phase one the storage system will be built and it is
expected to be completed and fully operational in Q2 2018. In addition to storage capabilities, it is
expected that in phase two the facility will also contain a GMP certified packaging and processing facility,
allowing Nuuvera to prepare bulk material shipped from Canada to Germany.

Nuuvera and Globalive Technologies partners to bring
blockchain to the global cannabis industry in groundbreaking
collaboration

TORONTO, Jan. 16, 2018 /CNW/ - NuuveraInc. ("Nuuvera") (TSXV:NUU)

NUUVERA ACQUIRES ONE OF SEVEN ITALIAN CANNABIS LICENSES

Becomes first Canadian company to hold license to import cannabis
Genoa, Italy (January 18, 2018) -- Nuuvera Inc. (“Nuuvera”) (TSXV:NUU), announced today
that it has acquired one of only seven licensees to import medical cannabis to Italy, and sell
medical cannabis wholesale to pharmacies in Italy. The license was acquired through the
purchase of 100% of the issued and outstanding shares in the Genoa based FL-Group, making
Nuuvera the first Canadian cannabis company to hold a license to serve the Italian market.

NUUVERA INC. ANNOUNCES INCREASE TO BOUGHT DEAL FINANCING

Toronto, Canada – January 18, 2018 – Nuuvera Inc. (TSXV:NUU) (the “Company”) is pleased to announce today
that, due to strong demand, it has agreed with Clarus Securities Inc. (“Clarus”) and Canaccord Genuity Corp.
(“Canaccord”, and collectively with Clarus the “Co-Lead Underwriters”) on behalf of a syndicate of underwriters
(collectively, the “Underwriters”), to increase the size of its previously announced C$35,000,020 “bought deal”
offering. Pursuant to the upsized deal terms, the Underwriters have agreed to purchase, on a “bought deal” basis
8,181,820 units of the Company (the “Units”) at a price of C$5.50 per Unit (the “Offering Price”) for aggregate
gross proceeds to the Company of C$45,000,010 (the “Offering”). Each Unit will be comprised of one common
share of the Company (a “Unit Share”) and one half of one common share purchase warrant (each whole common
share purchase warrant, a “Warrant”). Each Warrant will entitle the holder thereof to purchase one common share
of the Company.

Nuuvera and Aphria finalize offtake agreement for extra 60,000 kgs of cannabis production

LEAMINGTON, ON, Jan. 19, 2018 /CNW/ - Nuuvera Inc. ("Nuuvera") (TSXV: NUU) and Aphria Inc.
("Aphria") (TSX: APH & US OTC QB: APHQF) announced today that they have executed a previously
announced definitive offtake agreement for 60,000 kgs of cannabis production.